| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Colistin | 16 | 2019 | 217 | 7.63 | Why? |
| beta-Lactamases | 26 | 2019 | 759 | 6.27 | Why? |
| Drug Resistance, Bacterial | 18 | 2019 | 1414 | 4.43 | Why? |
| Escherichia coli Proteins | 10 | 2019 | 168 | 3.65 | Why? |
| Drug Resistance, Multiple, Bacterial | 13 | 2019 | 1115 | 3.63 | Why? |
| Klebsiella pneumoniae | 9 | 2018 | 658 | 3.41 | Why? |
| Bacterial Proteins | 14 | 2018 | 1318 | 3.24 | Why? |
| Anti-Bacterial Agents | 42 | 2021 | 10083 | 2.83 | Why? |
| Gram-Negative Bacteria | 6 | 2018 | 473 | 2.62 | Why? |
| Carbapenems | 8 | 2018 | 343 | 2.50 | Why? |
| Escherichia coli | 11 | 2019 | 1547 | 2.41 | Why? |
| Algeria | 18 | 2019 | 185 | 2.40 | Why? |
| Microbial Sensitivity Tests | 26 | 2019 | 2886 | 2.35 | Why? |
| Acinetobacter Infections | 6 | 2018 | 273 | 2.32 | Why? |
| Acinetobacter baumannii | 5 | 2018 | 378 | 2.10 | Why? |
| Enterobacteriaceae | 7 | 2018 | 395 | 1.69 | Why? |
| Plasmids | 7 | 2019 | 840 | 1.68 | Why? |
| Klebsiella Infections | 5 | 2018 | 466 | 1.63 | Why? |
| Farms | 3 | 2019 | 269 | 1.53 | Why? |
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 8 | 2019 | 449 | 1.38 | Why? |
| Enterobacter cloacae | 2 | 2017 | 58 | 1.37 | Why? |
| Multilocus Sequence Typing | 11 | 2019 | 264 | 1.27 | Why? |
| Escherichia coli Infections | 2 | 2019 | 348 | 1.14 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 1.09 | Why? |
| Genome, Bacterial | 3 | 2017 | 446 | 1.08 | Why? |
| Enterobacteriaceae Infections | 6 | 2018 | 529 | 1.04 | Why? |
| Transcription Factors | 2 | 2018 | 784 | 0.94 | Why? |
| Staphylococcus aureus | 2 | 2019 | 844 | 0.91 | Why? |
| Urinary Tract Infections | 2 | 2018 | 534 | 0.91 | Why? |
| Acinetobacter | 2 | 2017 | 58 | 0.87 | Why? |
| Chickens | 4 | 2019 | 1010 | 0.87 | Why? |
| Gene Expression Regulation, Bacterial | 2 | 2017 | 143 | 0.83 | Why? |
| Neisseria | 1 | 2019 | 9 | 0.82 | Why? |
| Feces | 7 | 2019 | 4235 | 0.80 | Why? |
| Bacterial Infections | 6 | 2018 | 2229 | 0.78 | Why? |
| Carbonyl Cyanide m-Chlorophenyl Hydrazone | 1 | 2018 | 4 | 0.77 | Why? |
| Lebanon | 5 | 2019 | 557 | 0.77 | Why? |
| Sulfadiazine | 1 | 2018 | 8 | 0.75 | Why? |
| Proteus vulgaris | 1 | 2017 | 1 | 0.74 | Why? |
| Arabinose | 1 | 2017 | 4 | 0.74 | Why? |
| Operon | 1 | 2017 | 12 | 0.74 | Why? |
| Staphylococcus saprophyticus | 1 | 2017 | 4 | 0.73 | Why? |
| Zidovudine | 1 | 2018 | 63 | 0.72 | Why? |
| Enterobacter | 1 | 2017 | 18 | 0.72 | Why? |
| Cockroaches | 1 | 2017 | 4 | 0.72 | Why? |
| Leukocidins | 1 | 2018 | 47 | 0.72 | Why? |
| Pseudomonas putida | 1 | 2017 | 12 | 0.71 | Why? |
| Exotoxins | 1 | 2018 | 54 | 0.71 | Why? |
| Superantigens | 1 | 2018 | 53 | 0.71 | Why? |
| Mycobacterium ulcerans | 1 | 2017 | 15 | 0.70 | Why? |
| Teicoplanin | 1 | 2020 | 191 | 0.70 | Why? |
| Rivers | 2 | 2017 | 304 | 0.70 | Why? |
| Columbidae | 1 | 2017 | 17 | 0.69 | Why? |
| Vancomycin Resistance | 1 | 2017 | 55 | 0.69 | Why? |
| Pseudomonas | 1 | 2017 | 65 | 0.69 | Why? |
| Enterotoxins | 1 | 2018 | 115 | 0.69 | Why? |
| Gene Silencing | 1 | 2018 | 213 | 0.68 | Why? |
| Rectum | 2 | 2017 | 495 | 0.67 | Why? |
| Salmonella | 1 | 2017 | 58 | 0.67 | Why? |
| Genes, Bacterial | 4 | 2018 | 207 | 0.64 | Why? |
| Bacteria | 8 | 2019 | 1897 | 0.64 | Why? |
| Oxytocin | 1 | 2017 | 76 | 0.64 | Why? |
| DNA, Bacterial | 5 | 2017 | 835 | 0.63 | Why? |
| Bacterial Toxins | 1 | 2018 | 185 | 0.63 | Why? |
| Gram-Positive Bacteria | 1 | 2017 | 230 | 0.63 | Why? |
| Blood Culture | 1 | 2018 | 308 | 0.59 | Why? |
| Culture Media | 1 | 2017 | 366 | 0.59 | Why? |
| France | 17 | 2020 | 12074 | 0.57 | Why? |
| Birds | 1 | 2017 | 412 | 0.56 | Why? |
| Vegetables | 1 | 2017 | 340 | 0.55 | Why? |
| Infertility, Male | 1 | 2019 | 322 | 0.54 | Why? |
| Carrier Proteins | 1 | 2017 | 513 | 0.54 | Why? |
| Disk Diffusion Antimicrobial Tests | 3 | 2017 | 36 | 0.52 | Why? |
| Semen | 1 | 2019 | 550 | 0.52 | Why? |
| Biological Evolution | 1 | 2019 | 641 | 0.51 | Why? |
| Lipopolysaccharides | 1 | 2017 | 848 | 0.50 | Why? |
| Poultry Diseases | 1 | 2018 | 588 | 0.47 | Why? |
| Molecular Epidemiology | 2 | 2017 | 1638 | 0.46 | Why? |
| Environmental Microbiology | 1 | 2016 | 575 | 0.45 | Why? |
| Azithromycin | 7 | 2021 | 3943 | 0.45 | Why? |
| Carrier State | 3 | 2017 | 2100 | 0.43 | Why? |
| Antimicrobial Stewardship | 1 | 2019 | 931 | 0.42 | Why? |
| Bacteremia | 3 | 2019 | 1372 | 0.42 | Why? |
| Editorial Policies | 1 | 2015 | 408 | 0.41 | Why? |
| Diagnostic Techniques and Procedures | 1 | 2012 | 265 | 0.39 | Why? |
| Swine | 1 | 2018 | 3352 | 0.39 | Why? |
| DNA Transposable Elements | 2 | 2018 | 91 | 0.35 | Why? |
| beta-Lactam Resistance | 3 | 2017 | 150 | 0.35 | Why? |
| RNA, Ribosomal, 16S | 3 | 2019 | 793 | 0.32 | Why? |
| Bacteriological Techniques | 2 | 2018 | 239 | 0.30 | Why? |
| Software | 1 | 2017 | 2501 | 0.29 | Why? |
| beta-Lactams | 2 | 2018 | 210 | 0.29 | Why? |
| Community-Acquired Infections | 1 | 2018 | 2328 | 0.29 | Why? |
| Animals | 20 | 2020 | 78931 | 0.28 | Why? |
| Cat-Scratch Disease | 1 | 2004 | 17 | 0.28 | Why? |
| Anti-Infective Agents | 2 | 2018 | 1766 | 0.28 | Why? |
| Bartonella henselae | 1 | 2004 | 28 | 0.28 | Why? |
| Rickettsia Infections | 3 | 2009 | 58 | 0.27 | Why? |
| Hydroxychloroquine | 7 | 2021 | 12447 | 0.27 | Why? |
| Bartonella quintana | 1 | 2003 | 27 | 0.27 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.25 | Why? |
| Gram-Negative Bacterial Infections | 2 | 2018 | 398 | 0.25 | Why? |
| Streptococcus pneumoniae | 2 | 2018 | 827 | 0.24 | Why? |
| Humans | 64 | 2021 | 930598 | 0.24 | Why? |
| Periodicals as Topic | 1 | 2015 | 1492 | 0.24 | Why? |
| Sequence Analysis, DNA | 4 | 2017 | 2830 | 0.23 | Why? |
| Genotype | 3 | 2018 | 4697 | 0.22 | Why? |
| Polymerase Chain Reaction | 9 | 2020 | 6740 | 0.22 | Why? |
| Islam | 2 | 2017 | 545 | 0.21 | Why? |
| Erythrocytes | 2 | 2004 | 617 | 0.21 | Why? |
| DNA-Directed RNA Polymerases | 2 | 2020 | 239 | 0.20 | Why? |
| Peptide Synthases | 1 | 2018 | 9 | 0.20 | Why? |
| Proton Ionophores | 1 | 2018 | 2 | 0.19 | Why? |
| Molecular Typing | 2 | 2017 | 280 | 0.19 | Why? |
| Trimethoprim | 1 | 2018 | 22 | 0.19 | Why? |
| Shewanella | 1 | 2017 | 4 | 0.18 | Why? |
| Proteus Infections | 1 | 2017 | 9 | 0.18 | Why? |
| Phylogeny | 7 | 2018 | 13341 | 0.18 | Why? |
| Methicillin | 1 | 2018 | 73 | 0.18 | Why? |
| Aminoglycosides | 1 | 2018 | 94 | 0.18 | Why? |
| Rodent Diseases | 1 | 2019 | 115 | 0.18 | Why? |
| Laos | 1 | 2018 | 144 | 0.18 | Why? |
| Drug Synergism | 2 | 2020 | 833 | 0.18 | Why? |
| Bacterial Typing Techniques | 1 | 2019 | 273 | 0.18 | Why? |
| Housing, Animal | 1 | 2017 | 53 | 0.17 | Why? |
| Mutagenesis, Insertional | 1 | 2017 | 92 | 0.17 | Why? |
| Cat Diseases | 1 | 2004 | 539 | 0.17 | Why? |
| Multigene Family | 1 | 2018 | 377 | 0.17 | Why? |
| Ecosystem | 2 | 2019 | 776 | 0.17 | Why? |
| Nitroimidazoles | 1 | 2017 | 69 | 0.17 | Why? |
| Hospitals | 6 | 2018 | 11793 | 0.17 | Why? |
| Antiviral Agents | 8 | 2021 | 41703 | 0.17 | Why? |
| Abattoirs | 1 | 2017 | 94 | 0.17 | Why? |
| Chromosome Mapping | 1 | 2017 | 178 | 0.17 | Why? |
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2018 | 170 | 0.16 | Why? |
| Animal Feed | 1 | 2017 | 72 | 0.16 | Why? |
| Gene Knockout Techniques | 1 | 2017 | 347 | 0.16 | Why? |
| Whole Genome Sequencing | 2 | 2018 | 3239 | 0.16 | Why? |
| Drug Utilization | 2 | 2019 | 619 | 0.16 | Why? |
| Mediterranean Region | 1 | 2017 | 276 | 0.16 | Why? |
| Farmers | 1 | 2019 | 280 | 0.16 | Why? |
| Poultry | 1 | 2018 | 437 | 0.16 | Why? |
| Prevalence | 4 | 2019 | 25773 | 0.15 | Why? |
| Quality-Adjusted Life Years | 1 | 2019 | 511 | 0.15 | Why? |
| Alcoholism | 1 | 2003 | 691 | 0.15 | Why? |
| Salvage Therapy | 1 | 2018 | 417 | 0.15 | Why? |
| Genomics | 2 | 2017 | 3118 | 0.15 | Why? |
| Selection, Genetic | 1 | 2019 | 691 | 0.14 | Why? |
| DNA Mutational Analysis | 1 | 2017 | 581 | 0.14 | Why? |
| Allografts | 1 | 2018 | 761 | 0.14 | Why? |
| Antiparasitic Agents | 1 | 2017 | 267 | 0.14 | Why? |
| Vancomycin | 1 | 2017 | 328 | 0.14 | Why? |
| Gastrointestinal Microbiome | 2 | 2018 | 1961 | 0.14 | Why? |
| Pneumonia, Pneumococcal | 1 | 2017 | 251 | 0.13 | Why? |
| Betacoronavirus | 13 | 2020 | 204454 | 0.13 | Why? |
| Thailand | 1 | 2018 | 1155 | 0.13 | Why? |
| Zinc | 1 | 2021 | 817 | 0.13 | Why? |
| Chloroquine | 4 | 2021 | 3152 | 0.12 | Why? |
| Disease Outbreaks | 3 | 2020 | 27595 | 0.12 | Why? |
| Pseudomonas Infections | 1 | 2017 | 425 | 0.12 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.12 | Why? |
| Pneumonia, Viral | 12 | 2020 | 243684 | 0.12 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.12 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.12 | Why? |
| Travel | 3 | 2017 | 7220 | 0.12 | Why? |
| Amino Acid Substitution | 1 | 2018 | 1706 | 0.11 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 1 | 2018 | 711 | 0.11 | Why? |
| Vulva | 1 | 2009 | 31 | 0.10 | Why? |
| Dermacentor | 1 | 2009 | 9 | 0.10 | Why? |
| Cerebral Hemorrhage | 1 | 2017 | 820 | 0.10 | Why? |
| Base Sequence | 1 | 2018 | 3581 | 0.10 | Why? |
| Drug Therapy, Combination | 5 | 2021 | 7268 | 0.10 | Why? |
| Israel | 1 | 2018 | 2751 | 0.10 | Why? |
| Tick-Borne Diseases | 1 | 2009 | 68 | 0.09 | Why? |
| Cystic Fibrosis | 1 | 2018 | 1104 | 0.09 | Why? |
| Dietary Supplements | 1 | 2021 | 2251 | 0.09 | Why? |
| Retrospective Studies | 9 | 2020 | 105322 | 0.09 | Why? |
| Microbiota | 1 | 2018 | 1240 | 0.09 | Why? |
| Rickettsia felis | 1 | 2006 | 5 | 0.08 | Why? |
| Female | 18 | 2021 | 380317 | 0.08 | Why? |
| Siphonaptera | 1 | 2006 | 21 | 0.08 | Why? |
| Lung Transplantation | 1 | 2018 | 1554 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Tunisia | 2 | 2018 | 543 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2017 | 3788 | 0.08 | Why? |
| Respiratory System | 1 | 2018 | 3213 | 0.07 | Why? |
| Adenosine Monophosphate | 2 | 2020 | 5652 | 0.07 | Why? |
| Alanine | 2 | 2020 | 5687 | 0.07 | Why? |
| Iran | 1 | 2018 | 5467 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2020 | 4027 | 0.07 | Why? |
| Chiroptera | 1 | 2020 | 3530 | 0.07 | Why? |
| Drug Repositioning | 2 | 2020 | 5683 | 0.07 | Why? |
| Phthiraptera | 1 | 2003 | 6 | 0.07 | Why? |
| Trench Fever | 1 | 2003 | 11 | 0.07 | Why? |
| Adult | 13 | 2021 | 244371 | 0.07 | Why? |
| Laboratories | 1 | 2017 | 2858 | 0.07 | Why? |
| Hospitals, University | 1 | 2016 | 4173 | 0.07 | Why? |
| Gastroscopes | 1 | 2003 | 8 | 0.07 | Why? |
| Insect Vectors | 1 | 2006 | 227 | 0.07 | Why? |
| Actinomycetales | 1 | 2003 | 9 | 0.07 | Why? |
| Public Health Surveillance | 1 | 2017 | 3129 | 0.07 | Why? |
| Glutaral | 1 | 2003 | 22 | 0.06 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.06 | Why? |
| Whipple Disease | 1 | 2003 | 38 | 0.06 | Why? |
| Peracetic Acid | 1 | 2003 | 68 | 0.06 | Why? |
| Pneumonia | 2 | 2020 | 5652 | 0.06 | Why? |
| Communicable Diseases, Emerging | 1 | 2017 | 2523 | 0.06 | Why? |
| Rodentia | 2 | 2019 | 235 | 0.06 | Why? |
| Animals, Domestic | 1 | 2004 | 272 | 0.06 | Why? |
| Metagenomics | 2 | 2018 | 823 | 0.06 | Why? |
| Microscopy, Confocal | 1 | 2003 | 343 | 0.06 | Why? |
| Molecular Diagnostic Techniques | 1 | 2017 | 4239 | 0.06 | Why? |
| Pandemics | 12 | 2020 | 389249 | 0.05 | Why? |
| Fluorescent Antibody Technique | 1 | 2004 | 835 | 0.05 | Why? |
| Male | 14 | 2021 | 367725 | 0.05 | Why? |
| Coronavirus | 2 | 2020 | 18339 | 0.05 | Why? |
| Population Surveillance | 1 | 2017 | 4967 | 0.05 | Why? |
| Heart Failure | 2 | 2020 | 6638 | 0.05 | Why? |
| Brazil | 1 | 2017 | 12582 | 0.05 | Why? |
| Rickettsia | 2 | 2009 | 101 | 0.05 | Why? |
| Archaea | 1 | 2018 | 30 | 0.05 | Why? |
| Primary Graft Dysfunction | 1 | 2018 | 44 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| DNA Gyrase | 1 | 2017 | 30 | 0.04 | Why? |
| Point-of-Care Systems | 1 | 2012 | 2955 | 0.04 | Why? |
| Cefotaxime | 1 | 2017 | 31 | 0.04 | Why? |
| DNA, Ribosomal | 1 | 2017 | 112 | 0.04 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2017 | 11367 | 0.04 | Why? |
| Acetyltransferases | 1 | 2017 | 30 | 0.04 | Why? |
| Asia, Southeastern | 1 | 2019 | 390 | 0.04 | Why? |
| Empirical Research | 1 | 2017 | 72 | 0.04 | Why? |
| Imipenem | 1 | 2017 | 57 | 0.04 | Why? |
| Gene Expression | 2 | 2018 | 3332 | 0.04 | Why? |
| Candida albicans | 1 | 2018 | 217 | 0.04 | Why? |
| Mutation | 1 | 2017 | 12376 | 0.04 | Why? |
| Cats | 1 | 2004 | 1890 | 0.04 | Why? |
| Amoxicillin | 1 | 2017 | 98 | 0.04 | Why? |
| Global Health | 2 | 2018 | 13911 | 0.04 | Why? |
| Hospitalization | 2 | 2018 | 54280 | 0.04 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.04 | Why? |
| Sus scrofa | 1 | 2017 | 205 | 0.04 | Why? |
| Saudi Arabia | 2 | 2017 | 4423 | 0.04 | Why? |
| SARS Virus | 1 | 2020 | 13021 | 0.04 | Why? |
| Middle Aged | 9 | 2021 | 270681 | 0.04 | Why? |
| Penicillins | 1 | 2017 | 132 | 0.04 | Why? |
| Macaca | 1 | 2017 | 388 | 0.04 | Why? |
| Cohort Studies | 1 | 2019 | 36005 | 0.04 | Why? |
| Biodiversity | 1 | 2019 | 546 | 0.04 | Why? |
| Aged | 8 | 2021 | 215776 | 0.04 | Why? |
| Viral Load | 3 | 2020 | 15850 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Serogroup | 1 | 2017 | 510 | 0.04 | Why? |
| Statistics as Topic | 1 | 2017 | 370 | 0.04 | Why? |
| Kinetics | 1 | 2003 | 3238 | 0.04 | Why? |
| Candidiasis | 1 | 2018 | 334 | 0.03 | Why? |
| Equipment Contamination | 1 | 2003 | 1308 | 0.03 | Why? |
| Travel Medicine | 1 | 2017 | 335 | 0.03 | Why? |
| Drug Interactions | 1 | 2021 | 1653 | 0.03 | Why? |
| Aged, 80 and over | 5 | 2021 | 88759 | 0.03 | Why? |
| Virus Attachment | 1 | 2020 | 1259 | 0.03 | Why? |
| Disinfectants | 1 | 2003 | 1077 | 0.03 | Why? |
| Homeless Persons | 1 | 2003 | 1171 | 0.03 | Why? |
| Terminology as Topic | 1 | 2017 | 546 | 0.03 | Why? |
| Young Adult | 5 | 2021 | 93724 | 0.03 | Why? |
| Cross-Sectional Studies | 1 | 2019 | 53120 | 0.03 | Why? |
| Treatment Outcome | 4 | 2021 | 51732 | 0.03 | Why? |
| Methyltransferases | 1 | 2017 | 720 | 0.03 | Why? |
| Dose-Response Relationship, Drug | 1 | 2021 | 3776 | 0.03 | Why? |
| Respiratory Function Tests | 1 | 2018 | 1755 | 0.03 | Why? |
| Crowding | 1 | 2017 | 731 | 0.03 | Why? |
| Skin Diseases, Papulosquamous | 1 | 2009 | 19 | 0.03 | Why? |
| Virulence | 1 | 2017 | 2172 | 0.03 | Why? |
| Animals, Wild | 1 | 2017 | 1028 | 0.03 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.02 | Why? |
| Blood Donors | 1 | 2003 | 2956 | 0.02 | Why? |
| Cluster Analysis | 1 | 2017 | 3001 | 0.02 | Why? |
| Drug Industry | 1 | 2017 | 689 | 0.02 | Why? |
| Adolescent | 4 | 2021 | 86841 | 0.02 | Why? |
| Scalp | 1 | 2009 | 82 | 0.02 | Why? |
| Child | 1 | 2018 | 70012 | 0.02 | Why? |
| Amino Acid Sequence | 1 | 2020 | 6049 | 0.02 | Why? |
| Pilot Projects | 1 | 2020 | 5182 | 0.02 | Why? |
| Bites and Stings | 1 | 2009 | 91 | 0.02 | Why? |
| Drug Evaluation, Preclinical | 1 | 2020 | 3347 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2004 | 10017 | 0.02 | Why? |
| Antifungal Agents | 1 | 2018 | 1828 | 0.02 | Why? |
| Blotting, Western | 1 | 2009 | 863 | 0.02 | Why? |
| Doxycycline | 1 | 2009 | 307 | 0.02 | Why? |
| Polymorphism, Single Nucleotide | 1 | 2020 | 3607 | 0.02 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2006 | 60 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Incidence | 2 | 2018 | 25622 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2018 | 3493 | 0.02 | Why? |
| Paris | 1 | 2009 | 1287 | 0.02 | Why? |
| Risk Factors | 3 | 2020 | 71621 | 0.02 | Why? |
| Fear | 1 | 2020 | 3607 | 0.02 | Why? |
| Antibodies, Monoclonal | 1 | 2004 | 8041 | 0.02 | Why? |
| Cell Line | 1 | 2020 | 12040 | 0.02 | Why? |
| Politics | 1 | 2017 | 1824 | 0.02 | Why? |
| Databases, Factual | 1 | 2018 | 6248 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.01 | Why? |
| DNA Primers | 1 | 2006 | 1170 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2020 | 17020 | 0.01 | Why? |
| Nasopharynx | 1 | 2020 | 10224 | 0.01 | Why? |
| Clinical Trials as Topic | 1 | 2020 | 7330 | 0.01 | Why? |
| Immunosuppressive Agents | 1 | 2018 | 6331 | 0.01 | Why? |
| South Africa | 1 | 2009 | 3326 | 0.01 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.01 | Why? |
| Skin | 1 | 2009 | 2096 | 0.01 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Equipment Reuse | 1 | 2003 | 985 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2017 | 15421 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2020 | 37182 | 0.01 | Why? |
| Lung | 1 | 2009 | 31049 | 0.00 | Why? |
| Disease Transmission, Infectious | 1 | 2003 | 9044 | 0.00 | Why? |